Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.

MLA

Sim, S. H., et al. “Prognostic Utility of Pre-Operative Circulating Osteopontin, Carbonic Anhydrase IX and CRP in Renal Cell Carcinoma.” British Journal of Cancer, vol. 107, no. 7, Sept. 2012, pp. 1131–37. EBSCOhost, https://doi.org/10.1038/bjc.2012.360.

APA

Sim, S. H., Messenger, M. P., Gregory, W. M., Wind, T. C., Vasudev, N. S., Cartledge, J., Thompson, D., Selby, P. J., & Banks, R. E. (2012). Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. British Journal of Cancer, 107(7), 1131–1137. https://doi.org/10.1038/bjc.2012.360

Chicago

Sim, S H, M P Messenger, W M Gregory, T C Wind, N S Vasudev, J Cartledge, D Thompson, P J Selby, and R E Banks. 2012. “Prognostic Utility of Pre-Operative Circulating Osteopontin, Carbonic Anhydrase IX and CRP in Renal Cell Carcinoma.” British Journal of Cancer 107 (7): 1131–37. doi:10.1038/bjc.2012.360.